SHALBY
|
|
| BOM : 540797     NSE : SHALBY     | |
| LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
| ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : None or < 25% |
Oct 29,2025 |
|
Price(EOD): ₹ 245.25
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Hospital & Healthcare Services |
| MCap: ₹ 2,648.70 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SHALBY | -0.8% | -0.8% | -2.4% |
| MAX HEALTHCARE INSTITUTE | -1.8% | 5.9% | 30.2% |
| APOLLO HOSPITALS ENTERPRISE | -1.4% | 4.7% | 13.3% |
| FORTIS HEALTHCARE | 0.6% | 13.2% | 80.8% |
| GLOBAL HEALTH | 1.7% | 5.8% | 27.2% |
| NARAYANA HRUDAYALAYA | 2.3% | 4.4% | 43.7% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES | 1.9% | 1.1% | 38.8% |
| DR LAL PATHLABS | 0.6% | -3.3% | 1.1% |
| ASTER DM HEALTHCARE | -2.9% | 11.9% | 57.9% |
FUNDAMENTAL ANALYSIS OF SHALBY
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF SHALBY
 | Ratio | Consolidated | |
|---|---|---|
|
P/E P/B P/S |
-514.86
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs -5.15 Cr
[Latest Qtr - Jun2025 - Consolidated Results ] 2.67
P/B Calculated based on Book Value of Rs 991.05 Cr
[Latest Year - Mar2025 - Consolidated Results ] 2.4
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 1,104.49 Cr
[Latest Qtr - Jun2025 - Consolidated Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
60% 30% -13% |
SHARE PRICE MOMENTUM OF SHALBY
SHALBY vs SENSEX
DEBT OF SHALBY
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2025 2024 2023 Avg_3yrs |
0.09 0.11 0.03 0.08 |
0.43 0.31 0.15 0.3 |
|
[Last Annual Data : Mar2025]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF SHALBY
| Pledged Promoter Shares |
0 % | |
|---|---|---|
| As on : Sep2025 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF SHALBY
| Consolidated | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
11.9% 99.33% 3165.22% 162.98% |
6.29% -8.12% -25.52% -47.91% |
| QtrlyTrend |
2 | |
| Latest Qtr: Jun2025 | ||
| Quarterly Result Analysis → | ||
SHALBY related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE SMALLCAP | 0.5% | 1.4% | 0.2% |
| BSE HEALTHCARE | -0.8% | 2.5% | 5.5% |
You may also like the below Video Courses
FAQ about SHALBY
Is SHALBY good for long term investment?
As on Oct 29,2025, the Fundamentals of SHALBY look Strong and hence it may be good for long term investment! See Financial Performance of SHALBY . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is SHALBY UnderValued or OverValued?
As on Oct 29,2025, SHALBY is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of SHALBY ?
As on Oct 29,2025, the Intrinsic Value of SHALBY is Rs. 188.72 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 153.01
Fair Value [Median EV / Sales Model] : Rs. 188.72
Fair Value [Median Price / Sales Model] : Rs. 282.34
Estimated Median Fair Value of SHALBY : Rs. 188.72
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.